SCHEMBL17016141

SCHEMBL17016141

c1ccc(-n2c3ccccc3c3ccc4c(ccn4-c4ccc5cc6ccccc6cc5c4)c32)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPK9 P45984 1/20 0.35
MAPK10 P53779 1/20 0.35
HTR7 P34969 1/20 0.34
KCNA3 P22001 1/20 0.34
ALDH1A1 P00352 2/20 0.33
BIRC5 O15392 1/20 0.33
F2 P00734 1/20 0.32
F10 P00742 1/20 0.32
PRSS1 P07477 1/20 0.32
TSHR P16473 1/20 0.31
CYP19A1 P11511 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
PGR P06401 1/20 0.31
HKDC1 Q2TB90 1/20 0.30
PTPN1 P18031 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17015191 0.95 KDM4E (0.38) KDM4EATML3MBTL1MAPK9MAPK10
SCHEMBL17016131 0.93 KDM4E (0.41) KDM4EATML3MBTL1MAPK9MAPK10
SCHEMBL16357493 0.91 KDM4E (0.39) KDM4EATML3MBTL1MAPK9MAPK10
SCHEMBL17015193 0.91 KDM4E (0.38) KDM4EATML3MBTL1MAPK9MAPK10
SCHEMBL17016140 0.91 KDM4E (0.38) KDM4EATML3MBTL1MAPK9MAPK10
SCHEMBL17016142 0.90 L3MBTL1 (0.37) KDM4EATML3MBTL1MAPK9MAPK10
SCHEMBL17015659 0.89 MAPK9 (0.33) KDM4EATML3MBTL1MAPK9MAPK10
SCHEMBL15802179 0.89 KDM4E (0.39) KDM4EATML3MBTL1MAPK9MAPK10
SCHEMBL17015657 0.88 KDM4E (0.35) KDM4EATML3MBTL1MAPK9MAPK10
SCHEMBL17015179 0.88 KDM4E (0.38) KDM4EATML3MBTL1HTR7ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 US disclosed
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME INMT, IDO1, IDO2 KDM4E 1286/4885ATM 3623/4885L3MBTL1 533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.